General Cannabis Corp Stock Current Valuation
| CANN Stock | USD 0.09 0 3.94% |
Valuation analysis of General Cannabis Corp helps investors to measure General Cannabis' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that General Cannabis' price fluctuation is out of control at this time. Calculation of the real value of General Cannabis Corp is based on 3 months time horizon. Increasing General Cannabis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for General Cannabis Corp is useful when determining the fair value of the General otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of General Cannabis. Since General Cannabis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of General OTC Stock. However, General Cannabis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0854 | Real 0.0711 | Hype 0.09 |
The real value of General OTC Stock, also known as its intrinsic value, is the underlying worth of General Cannabis Corp OTC Stock, which is reflected in its stock price. It is based on General Cannabis' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of General Cannabis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence General Cannabis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of General Cannabis Corp helps investors to forecast how General otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of General Cannabis more accurately as focusing exclusively on General Cannabis' fundamentals will not take into account other important factors: General Cannabis Corp OTC Stock Current Valuation Analysis
General Cannabis' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current General Cannabis Current Valuation | 35.32 M |
Most of General Cannabis' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, General Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, General Cannabis Corp has a Current Valuation of 35.32 M. This is 99.75% lower than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The current valuation for all United States stocks is 99.79% higher than that of the company.
General Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses General Cannabis' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of General Cannabis could also be used in its relative valuation, which is a method of valuing General Cannabis by comparing valuation metrics of similar companies.General Cannabis is currently under evaluation in current valuation category among related companies.
General Fundamentals
| Return On Equity | -0.73 | |||
| Return On Asset | -0.0299 | |||
| Profit Margin | (0.59) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 35.32 M | |||
| Shares Outstanding | 114.17 M | |||
| Shares Owned By Insiders | 82.81 % | |||
| Price To Earning | (0.58) X | |||
| Price To Book | 2.67 X | |||
| Price To Sales | 1.23 X | |||
| Revenue | 5.93 M | |||
| Gross Profit | 1.49 M | |||
| EBITDA | (6.6 M) | |||
| Net Income | (8.87 M) | |||
| Cash And Equivalents | 1.07 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.91 M | |||
| Debt To Equity | 0.99 % | |||
| Current Ratio | 0.61 X | |||
| Book Value Per Share | 0.08 X | |||
| Cash Flow From Operations | (2.65 M) | |||
| Earnings Per Share | (0.09) X | |||
| Number Of Employees | 77 | |||
| Beta | 1.09 | |||
| Market Capitalization | 18.61 M | |||
| Total Asset | 22.02 M | |||
| Retained Earnings | (33.4 M) | |||
| Working Capital | (16.51 M) | |||
| Current Asset | 1.42 M | |||
| Current Liabilities | 17.93 M | |||
| Z Score | 0.4 | |||
| Net Asset | 22.02 M |
About General Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze General Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of General Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of General Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with General Cannabis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if General Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in General Cannabis will appreciate offsetting losses from the drop in the long position's value.Moving against General OTC Stock
| 0.51 | NIO | Nio Class A Buyout Trend | PairCorr |
| 0.44 | LCID | Lucid Group Financial Report 13th of May 2024 | PairCorr |
| 0.42 | SIRI | Sirius XM Holding Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to General Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace General Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back General Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling General Cannabis Corp to buy it.
The correlation of General Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as General Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if General Cannabis Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for General Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in General Cannabis Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for General OTC Stock analysis
When running General Cannabis' price analysis, check to measure General Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy General Cannabis is operating at the current time. Most of General Cannabis' value examination focuses on studying past and present price action to predict the probability of General Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move General Cannabis' price. Additionally, you may evaluate how the addition of General Cannabis to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |